Guangzhou Innogen Pharmaceutical Group Co., Ltd (HKG:2591)

Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
44.48
+0.40 (0.91%)
Aug 29, 2025, 4:08 PM HKT
0.91%
Market Cap20.32B
Revenue (ttm)n/a
Net Income (ttm)-185.90M
Shares Out456.82M
EPS (ttm)-0.44
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume468,000
Average Volume2,430,045
Open44.06
Previous Close44.08
Day's Range44.06 - 45.82
52-Week Range43.62 - 74.00
Betan/a
RSIn/a
Earnings DateAug 29, 2025

About HKG:2591

Guangzhou Innogen Pharmaceutical Group Co., Ltd engages in development of drugs. Its products are used for treatment of metabolic diseases, including diabetes, obesity, and MASH; and other major central nervous system diseases. The company was incorporated in 2014 and is based in Shanghai, China. Guangzhou Innogen Group Co., Ltd. operates as a subsidiary of KPC Pharmaceuticals, Inc. [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2014
Country China
Stock Exchange Hong Kong Stock Exchange
Ticker Symbol 2591
Full Company Profile

Financial Performance

Financial numbers in CNY Financial Statements

News

There is no news available yet.